Investors Spar Over Ionis Director Pay Suit Deal In Chancery
An Ionis Pharmaceuticals Inc. investor is seeking to delay a Delaware Chancery Court hearing to consider a proposed deal to end a suit filed over allegedly excessive company director pay, after...To view the full article, register now.
Already a subscriber? Click here to view full article